Key result
Endovascular baroreflex amplification in patients with resistant hypertension significantly decreased mean gray matter cerebral blood flow from 48.9 at baseline to 43.4 ml/100 gr/min at 3 months (p=0.02).
Why the study?
Endovascular baroreflex amplification (EVBA) by MobiusHD implantation is hypothesized to lower blood pressure by decreasing sympathetic activity, but its impact on central sympathetic nerve circuits and cerebral blood flow in resistant hypertension required investigation.
Does endovascular baroreflex amplification alter central sympathetic nerve circuits and cerebral blood flow in patients with resistant hypertension?
Does endovascular baroreflex amplification alter central sympathetic nerve circuits and cerebral blood flow in patients with resistant hypertension?
Absolute Event Rate: 43.4% vs 48.9%
p-value: p=0.02
EVBA implantation in resistant hypertension alters cerebral blood flow and sympathetic nerve circuit activation during Valsalva maneuvers at 3 months.
Potential cerebral blood flow reduction with EVBA merits monitoring; leaves open effects on outcomes and sympathetic circuits.
Background Endovascular baroreflex amplification (EVBA) by implantation of the MobiusHD is hypothesized to lower blood pressure by decreasing sympathetic activity through the mechanism of the baroreflex. In the present exploratory study we investigated the impact of MobiusHD implantation on central sympathetic nerve circuits and cerebral blood flow (CBF) in patients with resistant hypertension. Materials and methods In thirteen patients, we performed blood oxygenation level-dependent functional magnetic resonance imaging (BOLD fMRI) at rest and during Valsalva maneuvers, before and 3 months after EVBA. Data were analyzed using a whole-brain approach and a brainstem-specific analysis. CBF was assessed using arterial spin labeling MRI. Results Resting-state fMRI analysis did not reveal significant differences in functional connectivity at 3 months after EVBA. For the Valsalva maneuver data, the whole-brain fMRI analysis revealed significantly increased activation in the posterior and anterior cingulate, the insular cortex, the precuneus, the left thalamus and the anterior cerebellum. The brainstem-specific fMRI analysis showed a significant increase in BOLD activity in the right midbrain 3 months after EVBA. Mean gray matter CBF (partial volume corrected) decreased significantly from 48.9 (9.9) ml/100 gr/min at baseline to 43.4 (13.0) ml/100 gr/min (p = 0.02) at 3 months. Conclusions This first fMRI pilot study in patients with resistant hypertension treated with EVBA showed a significant increase in BOLD activity during the Valsalva maneuver in brain regions related to sympathetic activity. No notable signal intensity changes were observed in brain areas involved in the baroreflex circuit. Future randomized controlled studies are needed to investigate whether the observed changes are directly caused by EVBA. Clinical trial registration www.clinicaltrials.gov , identifier: NCT02827032.
No takes yet. Share an insight, caveat, or question.
Groenland et al. (2022) studied Resistant hypertension (n=13). Endovascular baroreflex amplification (EVBA) via MobiusHD vs. Baseline was evaluated on Mean gray matter cerebral blood flow (CBF) (p=0.02). Endovascular baroreflex amplification in patients with resistant hypertension significantly decreased mean gray matter cerebral blood flow from 48.9 at baseline to 43.4 ml/100 gr/min at 3 months (p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: